CDT Equity Inc. (CDT)
| Market Cap | 47.24K -95.0% |
| Revenue (ttm) | n/a |
| Net Income | -37.15M |
| EPS | n/a |
| Shares Out | 56.23K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,389,114 |
| Open | 1.0800 |
| Previous Close | 1.3100 |
| Day's Range | 0.8210 - 1.0800 |
| 52-Week Range | 0.7800 - 355,000.0000 |
| Beta | 1.69 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |
About CDT
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also ... [Read more]
Financial Performance
Financial StatementsNews
CDT Equity Inc trading halted, news pending
19:50 EST CDT Equity (CDT) Inc trading halted, news pending
CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today welcomed a significant development in the U.S. regulatory la...
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today announced that it has entered into an evaluation agreement w...
CDT Equity highlights Sarborg patent filing
CDT Equity (CDT) noted the announcement from Sarborg Limited regarding intellectual property covering novel solid forms of a respiratory medicine. CDT holds 1,290 shares in Sarborg, representing 22.7%...
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding intelle...
CDT Equity notes announcement from Sarborg on expanding IP portfolio
CDT Equity (CDT) notes the announcement from Sarborg Limited regarding the filing of new intellectual property, IP, applying quantum sampling to disease biology and drug discovery. CDT holds 1,290 sha...
CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Equity Inc trading halted, news pending
19:50 EDT CDT Equity (CDT) Inc trading halted, news pending
CDT Equity announces 1-for-25 reverse stock split
CDT Equity (CDT) announces that its board of directors has approved a 1-for-25 reverse stock split of the Company’s common stock, to ensure continued compliance with the Nasdaq bid-price rule.
CDT Equity Inc. Announces Reverse Stock Split
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-25 rev...
CDT Equity enters partnership with QIMA Life Sciences
CDT Equity (CDT) announced that it has entered into a partnership with QIMA Life Sciences, a preclinical dermatology CRO, to explore the potential of several of CDT’s assets in autoimmune…
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Equity files to sell 16.83M shares of common stock for holders
This filing relates to the offer and sale from time to time by the selling stockholders of up to 16.83M shares of common stock. The company is not selling any…
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Equity appoints James Bligh as CEO
CDT Equity (CDT) announced the appointment of James Bligh, co-founder of Conduit Pharmaceuticals, as CEO. Andrew Regan has been appointed as CEO of Sarborg Limited. CDT holds a 22% strategic…
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Equity validates enhanced solid-form properties in IP portfolio
CDT Equity (CDT) announced that new solid forms and alternative crystal structures of its existing drug compounds, show enhanced physical property advantages, including improved stability, solubility,...
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that new solid forms and alternative crystal struc...
CDT Equity announces investment in Pep’d Inc.
CDT Equity (CDT) announced that it has entered into a SAFE note with Pep’d Inc., a US-based peptide company. Upon Pep’d closing an equity financing, this SAFE will automatically convert…
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has entered into a SAFE note with Pep'd In...
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that it has entered into a strategic transaction to...
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the fi...
CDT Equity Inc trading halted, news pending
19:50 EDT CDT Equity (CDT) Inc trading halted, news pending
CDT Equity announces 1-for-10 reverse stock split
CDT Equity (CDT) announced that its board of directors has approved a 1-for-10 reverse stock split of the company’s common stock, to ensure continued compliance with the Nasdaq bid-price rule.